Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

L.A. McKeown

June 27, 2025

News Daily News

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

Caitlin E. Cox

May 15, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

AHA Annual Statistics Show COVID’s Disruptive Impact

L.A. McKeown

January 30, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

Advertisement

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Semaglutide Has Similar Benefits in Women and Men With HFpEF

AHA Celebrates a Century by Looking Back, and Forward

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Mortality Risk Varies Among Patients With Very High LDL Levels

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

LDL Control Remains Poor in CAD Patients: NHANES

TCTMD’s Top 10 Most Popular Stories for April 2023

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

AHA Annual Statistics Show COVID’s Disruptive Impact

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content